Objective: Temporary biventricular pacing to treat low output states after cardiac surgery is an active area of investigation. Reoperative cases are not studied due to adhesions, which preclude left ventricular mobilization to place epicardial pacing wires. In such patients, inserting a temporary left ventricular lead via the coronary sinus cardioplegia cannula may allow for biventricular pacing. We developed a novel technique for intraoperative left ventricular lead placement.
Conclusions: Intraoperative biventricular pacing with a left ventricular pacing lead inserted via the coronary sinus cardioplegia cannula is feasible, using standard instrumentation and without requiring cardiac manipulation. This approach merits further study in patients undergoing reoperative cardiac surgery. (J Thorac Cardiovasc Surg 2011;142: In select patients with congestive heart failure (CHF), cardiac resynchronization therapy with biventricular pacing (BiVP) reduces morbidity. [1] [2] [3] [4] Permanent BiVP is indicated in advanced, chronic CHF associated with left ventricular (LV) dysfunction and intraventricular conduction delay. 5 The use of BiVP acutely improves cardiac contractility and cardiac output without increasing myocardial energy consumption. 6, 7 Therefore, it represents a potential treatment for low output heart failure after cardiac surgery, in which low ejection fraction is a strong predictor of poor postoperative outcomes. 8, 9 Temporary BiVP in the perioperative cardiac surgery setting is an active area of investigation, with numerous trials demonstrating acute improvements in cardiac output, arterial pressure, and ventricular synchrony. [10] [11] [12] [13] [14] [15] [16] [17] [18] To be able to achieve BiVP, such protocols involve attaching temporary pacing wires to the right atrial (RA), right ventricular (RV), and LV epicardium. An important limitation to this approach occurs in the setting of reoperative cardiac surgery, where adhesions preclude adequate mobilization of the heart to place pacing wires on the lateral or posterior LV. Patients with reduced ejection fraction who are undergoing reoperative surgery comprise a particularly high-risk group 19 and may especially benefit from temporary BiVP. Currently, such patients are excluded from the study. Consequently, development of an alternative method of achieving BiVP in these patients is needed. Here we report the feasibility and safety of a new technique for LV lead delivery via the coronary sinus (CS) cardioplegia cannula during open heart surgery.
METHODS
All animal studies were performed according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experimental protocol was approved by the Columbia University Institutional Animal Care and Use Committee. Eight Yorkshire pigs (28-33 kg) were anesthetized intramuscularly with atropine (0.02 mg/kg), ketamine (20 mg/kg), and xylazine (0.5 mg/kg), followed by oral endotracheal intubation and mechanical ventilation, as previously described. 20, 21 Anesthesia was maintained with isoflurane (1.75-2.5%) in oxygen. Arterial blood gas measurements were used to guide maintenance of adequate oxygenation and ventilation. Intravenous access was established via a posterior auricular vein, and 0.9% saline was administered at 5 mL/kg/hr. A femoral arterial line was inserted to measure arterial pressure. Standard limb leads were placed for surface electrocardiogram (ECG) monitoring. Pulse oximetry was monitored from the shaved tail. After a median sternotomy, the pericardium was incised longitudinally and traction sutures were placed to expose and support the heart. Bipolar temporary epicardial pacing leads (Medtronic 6495; Medtronic, Minneapolis, Minn) were sewn onto the RA appendage and anterior surface of the RV. The pacing leads were attached to a biventricular pacemaker (Medtronic InSync III) in a custom housing unit to allow lead connection with alligator clips. Proper lead function was then confirmed. Complete heart block was established with injection of 0.5 mL aliquots of 100% ethanol into the region of the bundle of His, at the base of the aorta, as previously described.
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A 13-French retrograde cardioplegia cannula was inserted via a RA free wall incision into the proximal CS and secured with a pursestring suture. Using the cardioplegia cannula as a guiding sheath, a 6-French bipolar LV pacing lead (Medtronic Attain 4194) with a stylet was inserted into the cardioplegia cannula and advanced into the CS. The LV lead was connected to the biventricular pacemaker, programmed at DDD 90 and an atrioventricular delay of 150 msec. Without lifting the heart, the lead was slowly advanced until LV capture was detected on ECG and confirmed by arterial pressure monitoring and visual inspection during LV pacing alone. Pacing function, including impedance and capture threshold, was measured with the stylet slightly withdrawn. If diaphragmatic stimulation was present, the lead was slowly advanced and empirically torqued clockwise or counterclockwise, as needed, until ventricular pacing without diaphragmatic stimulation was achieved, and thresholds and impedances were retested. Both bipolar and unipolar pacing configurations were tested to achieve the optimal pacing performance. After a minimum of 1-minute pacing, the lead was withdrawn from the cardioplegia cannula. Five insertion trials were tested for each animal. After the fifth trial, the heart was lifted and visually inspected for any evidence of bleeding or perforation, and the location of the LV lead tip was noted (Figure 1 ). ECG monitoring for arrhythmias was conducted throughout the experiment. The animals were humanely killed at the end of the experiment.
RESULTS
Capture success rates, electrical performance, and lead locations for each animal are shown in Table 1 . There were no episodes of arrhythmia, bleeding, perforation, or hemodynamic compromise during lead placement attempts.
The overall capture success rate for all attempts was 80%. The LV capture was achieved on at least one attempt in all 8 animals. In one animal, diaphragmatic pacing could not be avoided, despite lead repositioning and adjustment of pacing output and polarity. In the majority of animals, the LV lead tip was found to be in a coronary vein in the lateral or posterior aspect of the LV wall. The most common reason for failure to capture the LV was due to coursing of the LV lead into the left hemiazygous vein.
DISCUSSION
In patients with postoperative low output syndrome, temporary BiVP to improve hemodynamics and ventricular mechanics is an active area of investigation. [10] [11] [12] [13] [14] [15] [16] [17] [18] Patients undergoing reoperative cardiac surgery comprise a particularly high-risk group. 19 Thus, new techniques for temporary LV pacing are needed, so that the role of temporary BiVP can be studied in this cohort. To our knowledge, this is the first report of such a technique.
We demonstrate the feasibility and safety of a novel method for achieving temporary BiVP during open heart surgery. Our model replicates a common clinical technique The cardioplegia cannula not only accesses the CS, but it also it serves as a guiding sheath to direct the LV lead into a coronary branch vein, thereby addressing two major challenges to successful LV lead implantation in permanent cardiac resynchronization therapy. 23 Without using fluoroscopic imaging, LV capture was achieved in 80% of lead placement attempts, and LV capture without diaphragmatic stimulation was achieved in 7 of the 8 animals.
In the majority of cases, the LV lead was in a lateral or posterior position, which are considered to be generally favorable positions for BiVP. 24 We found that, in the majority of failures to capture the LV, the LV lead had coursed into the left hemiazygous vein. This problem would not arise in humans, as the left hemiazygous vein drains directly into the CS in pigs but not humans. 25 The model used here is only an approximation of the conditions during cardiac surgery, as cardiopulmonary bypass and cardioplegia were not used. Extension of the described technique to clinical reoperations would require a number of modifications. First, the LV lead would need to be introduced immediately following the last dose of retrograde cardioplegia and immediately before removal of the cardioplegia cannula. Next, final lead positioning and threshold testing would ideally be done on partial bypass, when electrophysiologic properties of the myocardium have recovered toward normal. Final lead positioning should also be done immediately before weaning from bypass, when the heart is maximally filled. This latter step would avoid lateral displacement of the right atrial wall by volume infusion from pulling the LV lead out of its optimized position.
Perioperative cardiac resynchronization is also being studied in pediatric patients undergoing surgery for congenital heart disease. 26, 27 This technique may provide an alternative approach to multi-site pacing in such patients.
Use of intraoperative transesophageal echocardiography may improve the success rate of LV lead placement. 28 In the future, hybrid operating rooms offering fluoroscopic imaging will refine vein selection and lead localization. Furthermore, specialized endocardial LV leads and lead delivery systems, designed specifically for temporary BiVP via the CS, may further improve the efficacy and safety of this approach. The safety and feasibility of this technique warrants further study in human subjects undergoing reoperative cardiac surgery.
